Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Tobin JV"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Correia SS; Cyclerion Therapeutics, 245 First St., Riverview II, 18th Floor, Cambridge, MA, 02142, USA., Liu G; Cyclerion Therapeutics, 245 First St., Riverview II, 18th Floor, Cambridge, MA, 02142, USA., Jacobson S; Cyclerion Therapeutics, 245 First St., Riverview II, 18th Floor, Cambridge, MA, 02142, USA., Bernier SG; Cyclerion Therapeutics, 245 First St., Riverview II, 18th Floor, Cambridge, MA, 02142, USA., Tobin JV; Cyclerion Therapeutics, 245 First St., Riverview II, 18th Floor, Cambridge, MA, 02142, USA., Schwartzkopf CD; Cyclerion Therapeutics, 245 First St., Riverview II, 18th Floor, Cambridge, MA, 02142, USA., Atwater E; Cyclerion Therapeutics, 245 First St., Riverview II, 18th Floor, Cambridge, MA, 02142, USA., Lonie E; Ironwood Pharmaceuticals, Cambridge, MA, 02142, USA., Rivers S; Cyclerion Therapeutics, 245 First St., Riverview II, 18th Floor, Cambridge, MA, 02142, USA., Carvalho A; Cyclerion Therapeutics, 245 First St., Riverview II, 18th Floor, Cambridge, MA, 02142, USA., Germano P; Cyclerion Therapeutics, 245 First St., Riverview II, 18th Floor, Cambridge, MA, 02142, USA., Tang K; Ironwood Pharmaceuticals, Cambridge, MA, 02142, USA., Iyengar RR; Cyclerion Therapeutics, 245 First St., Riverview II, 18th Floor, Cambridge, MA, 02142, USA., Currie MG; Cyclerion Therapeutics, 245 First St., Riverview II, 18th Floor, Cambridge, MA, 02142, USA., Hadcock JR; Cyclerion Therapeutics, 245 First St., Riverview II, 18th Floor, Cambridge, MA, 02142, USA., Winrow CJ; Cyclerion Therapeutics, 245 First St., Riverview II, 18th Floor, Cambridge, MA, 02142, USA., Jones JE; Cyclerion Therapeutics, 245 First St., Riverview II, 18th Floor, Cambridge, MA, 02142, USA. jjones@cyclerion.com.
Publikováno v:
Journal of neuroinflammation [J Neuroinflammation] 2021 Sep 18; Vol. 18 (1), pp. 213. Date of Electronic Publication: 2021 Sep 18.
Autor:
Zimmer DP; Research and Development, Cyclerion Therapeutics, Cambridge, MA, United States., Shea CM; Research and Development, Cyclerion Therapeutics, Cambridge, MA, United States., Tobin JV; Research and Development, Cyclerion Therapeutics, Cambridge, MA, United States., Tchernychev B; Research and Development, Cyclerion Therapeutics, Cambridge, MA, United States., Germano P; Research and Development, Cyclerion Therapeutics, Cambridge, MA, United States., Sykes K; Research and Development, Ironwood Pharmaceuticals, Boston, MA, United States., Banijamali AR; Research and Development, Ironwood Pharmaceuticals, Boston, MA, United States., Jacobson S; Research and Development, Cyclerion Therapeutics, Cambridge, MA, United States., Bernier SG; Research and Development, Cyclerion Therapeutics, Cambridge, MA, United States., Sarno R; Research and Development, Cyclerion Therapeutics, Cambridge, MA, United States., Carvalho A; Research and Development, Cyclerion Therapeutics, Cambridge, MA, United States., Chien YT; Research and Development, Cyclerion Therapeutics, Cambridge, MA, United States., Graul R; Research and Development, Cyclerion Therapeutics, Cambridge, MA, United States., Buys ES; Research and Development, Cyclerion Therapeutics, Cambridge, MA, United States., Jones JE; Research and Development, Cyclerion Therapeutics, Cambridge, MA, United States., Wakefield JD; Research and Development, Cyclerion Therapeutics, Cambridge, MA, United States., Price GM; Research and Development, Cyclerion Therapeutics, Cambridge, MA, United States., Chickering JG; Research and Development, Cyclerion Therapeutics, Cambridge, MA, United States., Milne GT; Research and Development, Cyclerion Therapeutics, Cambridge, MA, United States., Currie MG; Research and Development, Cyclerion Therapeutics, Cambridge, MA, United States., Masferrer JL; Research and Development, Cyclerion Therapeutics, Cambridge, MA, United States.
Publikováno v:
Frontiers in pharmacology [Front Pharmacol] 2020 Apr 08; Vol. 11, pp. 419. Date of Electronic Publication: 2020 Apr 08 (Print Publication: 2020).
Autor:
Banijamali AR; Department of Drug Metabolism and Pharmacokinetics, Cyclerion Therapeutics, Cambridge, MA, USA., Carvalho AE; Department of Drug Metabolism and Pharmacokinetics, Cyclerion Therapeutics, Cambridge, MA, USA., Wakefield JD; Department of Drug Metabolism and Pharmacokinetics, Cyclerion Therapeutics, Cambridge, MA, USA., Germano P; Department of Drug Metabolism and Pharmacokinetics, Cyclerion Therapeutics, Cambridge, MA, USA., Barden TC; Department of Drug Metabolism and Pharmacokinetics, Cyclerion Therapeutics, Cambridge, MA, USA., Tobin JV; Department of Drug Metabolism and Pharmacokinetics, Cyclerion Therapeutics, Cambridge, MA, USA., Zimmer DP; Department of Drug Metabolism and Pharmacokinetics, Cyclerion Therapeutics, Cambridge, MA, USA., Masferrer JL; Department of Drug Metabolism and Pharmacokinetics, Cyclerion Therapeutics, Cambridge, MA, USA., Profy AT; Department of Drug Metabolism and Pharmacokinetics, Cyclerion Therapeutics, Cambridge, MA, USA., Currie MG; Department of Drug Metabolism and Pharmacokinetics, Cyclerion Therapeutics, Cambridge, MA, USA., Todd Milne G; Department of Drug Metabolism and Pharmacokinetics, Cyclerion Therapeutics, Cambridge, MA, USA.
Publikováno v:
Pharmacology research & perspectives [Pharmacol Res Perspect] 2020 Apr; Vol. 8 (2), pp. e00579.
Autor:
Tobin JV; Ironwood Pharmaceuticals, Cambridge, Massachusetts jtobin@ironwoodpharma.com., Zimmer DP; Ironwood Pharmaceuticals, Cambridge, Massachusetts., Shea C; Ironwood Pharmaceuticals, Cambridge, Massachusetts., Germano P; Ironwood Pharmaceuticals, Cambridge, Massachusetts., Bernier SG; Ironwood Pharmaceuticals, Cambridge, Massachusetts., Liu G; Ironwood Pharmaceuticals, Cambridge, Massachusetts., Long K; Ironwood Pharmaceuticals, Cambridge, Massachusetts., Miyashiro J; Ironwood Pharmaceuticals, Cambridge, Massachusetts., Ranganath S; Ironwood Pharmaceuticals, Cambridge, Massachusetts., Jacobson S; Ironwood Pharmaceuticals, Cambridge, Massachusetts., Tang K; Ironwood Pharmaceuticals, Cambridge, Massachusetts., Im GJ; Ironwood Pharmaceuticals, Cambridge, Massachusetts., Sheppeck J 2nd; Ironwood Pharmaceuticals, Cambridge, Massachusetts., Moore JD; Ironwood Pharmaceuticals, Cambridge, Massachusetts., Sykes K; Ironwood Pharmaceuticals, Cambridge, Massachusetts., Wakefield J; Ironwood Pharmaceuticals, Cambridge, Massachusetts., Sarno R; Ironwood Pharmaceuticals, Cambridge, Massachusetts., Banijamali AR; Ironwood Pharmaceuticals, Cambridge, Massachusetts., Profy AT; Ironwood Pharmaceuticals, Cambridge, Massachusetts., Milne GT; Ironwood Pharmaceuticals, Cambridge, Massachusetts., Currie MG; Ironwood Pharmaceuticals, Cambridge, Massachusetts., Masferrer JL; Ironwood Pharmaceuticals, Cambridge, Massachusetts.
Publikováno v:
The Journal of pharmacology and experimental therapeutics [J Pharmacol Exp Ther] 2018 Jun; Vol. 365 (3), pp. 664-675. Date of Electronic Publication: 2018 Apr 11.
Autor:
Tchernychev B; Ironwood Pharmaceuticals, Cambridge, Massachusetts (B.T., P.G., M.M.K., R.M.S., D.W., J.V.T., A.F., G.H., A.P.B., C.B.K., M.G.C., I.S.-S.); and Ralph N. Adams Institute for Bioanalytical Chemistry, Department of Chemistry, University of Kansas, Lawrence, Kansas (S.R.T., C.E.L.)., Ge P; Ironwood Pharmaceuticals, Cambridge, Massachusetts (B.T., P.G., M.M.K., R.M.S., D.W., J.V.T., A.F., G.H., A.P.B., C.B.K., M.G.C., I.S.-S.); and Ralph N. Adams Institute for Bioanalytical Chemistry, Department of Chemistry, University of Kansas, Lawrence, Kansas (S.R.T., C.E.L.)., Kessler MM; Ironwood Pharmaceuticals, Cambridge, Massachusetts (B.T., P.G., M.M.K., R.M.S., D.W., J.V.T., A.F., G.H., A.P.B., C.B.K., M.G.C., I.S.-S.); and Ralph N. Adams Institute for Bioanalytical Chemistry, Department of Chemistry, University of Kansas, Lawrence, Kansas (S.R.T., C.E.L.)., Solinga RM; Ironwood Pharmaceuticals, Cambridge, Massachusetts (B.T., P.G., M.M.K., R.M.S., D.W., J.V.T., A.F., G.H., A.P.B., C.B.K., M.G.C., I.S.-S.); and Ralph N. Adams Institute for Bioanalytical Chemistry, Department of Chemistry, University of Kansas, Lawrence, Kansas (S.R.T., C.E.L.)., Wachtel D; Ironwood Pharmaceuticals, Cambridge, Massachusetts (B.T., P.G., M.M.K., R.M.S., D.W., J.V.T., A.F., G.H., A.P.B., C.B.K., M.G.C., I.S.-S.); and Ralph N. Adams Institute for Bioanalytical Chemistry, Department of Chemistry, University of Kansas, Lawrence, Kansas (S.R.T., C.E.L.)., Tobin JV; Ironwood Pharmaceuticals, Cambridge, Massachusetts (B.T., P.G., M.M.K., R.M.S., D.W., J.V.T., A.F., G.H., A.P.B., C.B.K., M.G.C., I.S.-S.); and Ralph N. Adams Institute for Bioanalytical Chemistry, Department of Chemistry, University of Kansas, Lawrence, Kansas (S.R.T., C.E.L.)., Thomas SR; Ironwood Pharmaceuticals, Cambridge, Massachusetts (B.T., P.G., M.M.K., R.M.S., D.W., J.V.T., A.F., G.H., A.P.B., C.B.K., M.G.C., I.S.-S.); and Ralph N. Adams Institute for Bioanalytical Chemistry, Department of Chemistry, University of Kansas, Lawrence, Kansas (S.R.T., C.E.L.)., Lunte CE; Ironwood Pharmaceuticals, Cambridge, Massachusetts (B.T., P.G., M.M.K., R.M.S., D.W., J.V.T., A.F., G.H., A.P.B., C.B.K., M.G.C., I.S.-S.); and Ralph N. Adams Institute for Bioanalytical Chemistry, Department of Chemistry, University of Kansas, Lawrence, Kansas (S.R.T., C.E.L.)., Fretzen A; Ironwood Pharmaceuticals, Cambridge, Massachusetts (B.T., P.G., M.M.K., R.M.S., D.W., J.V.T., A.F., G.H., A.P.B., C.B.K., M.G.C., I.S.-S.); and Ralph N. Adams Institute for Bioanalytical Chemistry, Department of Chemistry, University of Kansas, Lawrence, Kansas (S.R.T., C.E.L.)., Hannig G; Ironwood Pharmaceuticals, Cambridge, Massachusetts (B.T., P.G., M.M.K., R.M.S., D.W., J.V.T., A.F., G.H., A.P.B., C.B.K., M.G.C., I.S.-S.); and Ralph N. Adams Institute for Bioanalytical Chemistry, Department of Chemistry, University of Kansas, Lawrence, Kansas (S.R.T., C.E.L.)., Bryant AP; Ironwood Pharmaceuticals, Cambridge, Massachusetts (B.T., P.G., M.M.K., R.M.S., D.W., J.V.T., A.F., G.H., A.P.B., C.B.K., M.G.C., I.S.-S.); and Ralph N. Adams Institute for Bioanalytical Chemistry, Department of Chemistry, University of Kansas, Lawrence, Kansas (S.R.T., C.E.L.)., Kurtz CB; Ironwood Pharmaceuticals, Cambridge, Massachusetts (B.T., P.G., M.M.K., R.M.S., D.W., J.V.T., A.F., G.H., A.P.B., C.B.K., M.G.C., I.S.-S.); and Ralph N. Adams Institute for Bioanalytical Chemistry, Department of Chemistry, University of Kansas, Lawrence, Kansas (S.R.T., C.E.L.)., Currie MG; Ironwood Pharmaceuticals, Cambridge, Massachusetts (B.T., P.G., M.M.K., R.M.S., D.W., J.V.T., A.F., G.H., A.P.B., C.B.K., M.G.C., I.S.-S.); and Ralph N. Adams Institute for Bioanalytical Chemistry, Department of Chemistry, University of Kansas, Lawrence, Kansas (S.R.T., C.E.L.)., Silos-Santiago I; Ironwood Pharmaceuticals, Cambridge, Massachusetts (B.T., P.G., M.M.K., R.M.S., D.W., J.V.T., A.F., G.H., A.P.B., C.B.K., M.G.C., I.S.-S.); and Ralph N. Adams Institute for Bioanalytical Chemistry, Department of Chemistry, University of Kansas, Lawrence, Kansas (S.R.T., C.E.L.) isilos-santiago@ironwoodpharma.com.
Publikováno v:
The Journal of pharmacology and experimental therapeutics [J Pharmacol Exp Ther] 2015 Oct; Vol. 355 (1), pp. 48-56. Date of Electronic Publication: 2015 Jul 27.
Autor:
Busby RW; Ironwood Pharmaceuticals, Inc., 301 Binney Street, Cambridge, MA 02142, USA. rbusby@ironwoodpharma.com, Kessler MM, Bartolini WP, Bryant AP, Hannig G, Higgins CS, Solinga RM, Tobin JV, Wakefield JD, Kurtz CB, Currie MG
Publikováno v:
The Journal of pharmacology and experimental therapeutics [J Pharmacol Exp Ther] 2013 Jan; Vol. 344 (1), pp. 196-206. Date of Electronic Publication: 2012 Oct 22.
Autor:
Busby RW; Ironwood Pharmaceuticals Inc., 301 Binney Street, Cambridge, MA, 02142, USA. rbusby@ironwoodpharma.com, Bryant AP, Bartolini WP, Cordero EA, Hannig G, Kessler MM, Mahajan-Miklos S, Pierce CM, Solinga RM, Sun LJ, Tobin JV, Kurtz CB, Currie MG
Publikováno v:
European journal of pharmacology [Eur J Pharmacol] 2010 Dec 15; Vol. 649 (1-3), pp. 328-35. Date of Electronic Publication: 2010 Sep 20.
Autor:
Bryant AP; Ironwood Pharmaceuticals, Inc., 320 Bent Street, Cambridge, MA 02141, USA. abryant@ironwoodpharma.com, Busby RW, Bartolini WP, Cordero EA, Hannig G, Kessler MM, Pierce CM, Solinga RM, Tobin JV, Mahajan-Miklos S, Cohen MB, Kurtz CB, Currie MG
Publikováno v:
Life sciences [Life Sci] 2010 May 08; Vol. 86 (19-20), pp. 760-5. Date of Electronic Publication: 2010 Mar 20.